Heart Clinical Trials

2 recruiting

Heart Trials at a Glance

1,390 actively recruiting trials for heart are listed on ClinicalTrialsFinder across 6 cities in 90 countries. The largest study group is Not Applicable with 553 trials, with the heaviest enrollment activity in New York, Boston, and Dallas. Lead sponsors running heart studies include Mayo Clinic, Yale University, and China National Center for Cardiovascular Diseases.

Treatments under study

About Heart Clinical Trials

Looking for clinical trials for Heart? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Heart trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Heart clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,390 trials

Recruiting

Coroflex® ISAR NEO PMCF Study

Coronary Artery Disease (CAD)Ischemic Heart Disease
Fundación EPIC3,000 enrolled22 locationsNCT05698732
Recruiting

Personalized Environment and Genes Study

AsthmaDiabetesHeart Disease
National Institute of Environmental Health Sciences (NIEHS)25,000 enrolled1 locationNCT00341237
Recruiting

Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction

Type 2 DiabetesHeart Failure With Preserved Ejection Fraction
University of Leicester60 enrolled1 locationNCT06652763
Recruiting
Not Applicable

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

Congenital Heart DiseaseCongenital Heart Disease (CHD)
Starlight Cardiovascular Inc35 enrolled8 locationsNCT07114718
Recruiting
Phase 3

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Heart Failure
Boehringer Ingelheim4,200 enrolled638 locationsNCT06935370
Recruiting
Not Applicable

Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker

Heart FailureBradycardia
Samsung Medical Center106 enrolled1 locationNCT07563153
Recruiting
Phase 3

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Heart Failure
Boehringer Ingelheim6,000 enrolled653 locationsNCT06424288
Recruiting

REGistry of Long-term AnTithrombotic TherApy-1

Peripheral Artery DiseaseCoronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation2,000 enrolled1 locationNCT04347200
Recruiting
Not Applicable

The Role of Stress in Cardiac Arrest (Cortizol CPR)

Cardiac Arrest (CA)Heart AttackChronic Stress+1 more
University Hospital Pilsen136 enrolled1 locationNCT07285915
Recruiting
Phase 2

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

Heart Failure
Pfizer620 enrolled135 locationsNCT06991257
Recruiting
Phase 4

Allograft Dysfunction in Heart Transplant

Heart Transplant Failure and Rejection
Paul Kim376 enrolled1 locationNCT03102125
Recruiting
Not Applicable

HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management

Heart Failure
United Innomed(Shanghai) Limited330 enrolled1 locationNCT07402239
Recruiting
Not Applicable

The Salt Study for Heart Failure

Heart Failure
Maya Guglin, MD500 enrolled1 locationNCT07560592
Recruiting
Not Applicable

Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions

Genetic TestingPulmonary Arterial HypertensionHeart Defects, Congenital
Universitaire Ziekenhuizen KU Leuven21 enrolled1 locationNCT02691689
Recruiting
Not Applicable

Ablation of Consecutive Atrial Tachycardia

Arrhythmias, CardiacHeart DiseasesAtrial Tachycardia+1 more
Evangelical Hospital Düsseldorf100 enrolled6 locationsNCT05239364
Recruiting
Not Applicable

Effects of Resistance Training on Sarcopenia in Older Patients With Chronic Heart Failure

Chronic Heart FailureSarcopenia in Elderly
Kieu Nguyen Dang Phuong146 enrolled2 locationsNCT06785168
Recruiting
Not Applicable

DRAIN: DRainage in Acute Decompensated Heart faIlure With Pleural effusioNs

Congestive Heart Failure(CHF)Pleural Effusion Due to Congestive Heart Failure
Albany Medical College216 enrolled1 locationNCT07419360
Recruiting
Not Applicable

Sternal Plating High Risk

Heart Diseases
University Hospitals Cleveland Medical Center250 enrolled1 locationNCT06660186
Recruiting
Phase 3

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Heart FailureAcute Heart Failure
Colorado Prevention Center5,200 enrolled156 locationsNCT06008197
Recruiting
Not Applicable

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

Heart FailureHeart Failure NYHA Class IIIHeart Failure NYHA Class II
CVRx, Inc.2,500 enrolled2 locationsNCT07232030